Evidence map›Paper›PMID 31847167›Full record

ArticleCancers2019

Dose-Limiting Organs at Risk in Carbon Ion Re-Irradiation of Head and Neck Malignancies: An Individual Risk-Benefit Tradeoff.

Thomas Held, Semi B Harrabi, Kristin Lang, Sati Akbaba, Paul Windisch, Denise Bernhardt, Stefan Rieken, Klaus Herfarth, Jürgen Debus, Sebastian Adeberg

Abstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Thomas HeldHeidelberg University Hospital, Department of Radiation Oncology, 69120 Heidelberg, Germany.ORCID 0000-0002-3913-4693
Semi B HarrabiHeidelberg University Hospital, Department of Radiation Oncology, 69120 Heidelberg, Germany.
Kristin LangHeidelberg University Hospital, Department of Radiation Oncology, 69120 Heidelberg, Germany.
Sati AkbabaHeidelberg University Hospital, Department of Radiation Oncology, 69120 Heidelberg, Germany.ORCID 0000-0001-8363-2668
Paul WindischUniversity Hospital of Zurich, Department of Radiation Oncology, 8091 Zurich, Switzerland.
Denise BernhardtHeidelberg University Hospital, Department of Radiation Oncology, 69120 Heidelberg, Germany.
Stefan RiekenHeidelberg University Hospital, Department of Radiation Oncology, 69120 Heidelberg, Germany.
Klaus HerfarthHeidelberg University Hospital, Department of Radiation Oncology, 69120 Heidelberg, Germany.
Jürgen DebusHeidelberg University Hospital, Department of Radiation Oncology, 69120 Heidelberg, Germany.
Sebastian AdebergHeidelberg University Hospital, Department of Radiation Oncology, 69120 Heidelberg, Germany.ORCID 0000-0001-8463-514X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

dose constraintshead and neck cancerheavy ion therapylocal recurrenceplanning target volume

Identifiers

PMID31847167
PMCPMC6966577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.